Kaposi sarcoma care and research partnership in Zambia and Tanzania
Official title: Kaposi Sarcoma in the Era of ART in Africa Program (KEAAP)
Funded at Lsu Health Sciences Center · NIH-11412991 · Data updated 2026-11-12
This program connects hospitals in Zambia, Tanzania, and the U.S. to improve how Kaposi sarcoma is found, treated, and understood in people living with HIV on antiretroviral therapy.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Lsu Health Sciences Center NIH-funded |
| Lab location | 1 site (New Orleans, United States) |
| Project start | September 1, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $251,791 |
| NIH project number | 3U54CA277846-03S1 |
| Project ID | NIH-11412991 on NIH RePORTER |
Who could benefit from this research
✓Could help
People living with HIV in Zambia or Tanzania who have or are at risk for Kaposi sarcoma, including those receiving antiretroviral therapy, would be the most likely candidates to take part.
✕Less likely to help
People without HIV, patients living outside the study regions, or those with unrelated health conditions are unlikely to see direct benefit from this program.
What this research studies
From a patient viewpoint, this program builds a network between cancer hospitals in Zambia and Tanzania and a U.S. cancer center to do clinical and laboratory work on Kaposi sarcoma (KS). Teams will work on better ways to detect KS, follow patient care and outcomes, and study how the disease develops and how the immune system responds. The program also aims to strengthen local research and clinical capacity so care can be improved where patients live. Research activities may include collecting clinical data, tissue samples, and linking lab findings to patient care improvements.
Why it matters
Potential benefit: If successful, this program could lead to earlier diagnosis, better treatment options, and fewer deaths from Kaposi sarcoma for people living with HIV in the participating countries.
How similar studies have gone: Previous integrated HIV–cancer programs in the region have improved KS diagnosis and care, but multi-country efforts linking lab science to patient outcomes at this scale remain limited.
Where this research is happening
-
Lsu Health Sciences Center
New Orleans, United States Active
Researchers
- Principal investigator: Wood, Charles — Lsu Health Sciences Center
- Study coordinator: Wood, Charles
Related research
Other NIH-funded projects on the same topics.
-
Precision 3D Imaging to Monitor Kaposi Sarcoma (KS) with SkinScan3D
A new portable 3D imaging tool called SkinScan3D will help doctors measure KS skin lesions more accurately and quickly, especially in people living with HIV.
-
Precision 3D Imaging to Track Kaposi Sarcoma (KS) with SkinScan3D
A new 3D imaging tool called SkinScan3D helps doctors monitor Kaposi sarcoma lesions more accurately and quickly, especially in settings with high KS burden like East Africa and in U.S. clinics with HIV patients.
-
Kaposi Sarcoma care and research in Africa during ART era
A collaborative program to better understand and improve diagnosis, treatment, and prevention of Kaposi sarcoma for people living with HIV in Zambia and Tanzania.
-
Kaposi Sarcoma in Africa: ART Era Research Network
A collaborative program in Africa and the United States will study Kaposi sarcoma in people living with HIV on ART to improve diagnosis, treatment, and prevention.
-
Kaposi Sarcoma in Africa in the ART Era
This grant supports research to improve how Kaposi sarcoma is detected, treated, and understood in people living with HIV in Zambia and Tanzania during ART, with collaboration between African hospitals and a U.S. center.
-
Faster detection and connection to care for people with HIV who develop Kaposi sarcoma in East Africa
This project aims to speed up finding people with HIV diagnosed with Kaposi sarcoma in East Africa and help them get linked to care more quickly.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.